UPF1 contributes to the maintenance of endometrial cancer stem cell phenotype by stabilizing LINC00963

Cell Death Dis. 2022 Mar 22;13(3):257. doi: 10.1038/s41419-022-04707-x.

Abstract

Endometrial cancer stem cells (ECSCs) play a vital role in endometrial cancer (EC) metastasis, relapse, and chemoresistance. However, the molecular mechanisms that sustain ECSCs remain elusive. Here, we showed that the expression of UPF1 was upregulated in EC tissues and ECSCs and correlated with poor clinicopathological characteristics. UPF1 silencing suppressed ECSC hallmarks, such as sphere formation ability, carboplatin resistance, migration and invasion, and cell cycle progression. UPF1 regulated the behavior and fate of ECSCs by stabilizing LINC00963. LINC00963 further shares the same miRNA response element with the core transcription factor SOX2 and relieved the suppression of SOX2 by miR-508-5p in self-renewing ECSCs. Notably, inhibition of UPF1 and LINC00963 in combination severely impaired the in vivo tumorigenic potential of ECSCs. We demonstrate that the UPF1/LINC00963/miR-508-5p/SOX2 axis has potential value in modulating ECSC maintenance, chemoresistance, and tumorigenesis in EC, which highlights a novel promising target for EC treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Endometrial Neoplasms* / genetics
  • Endometrial Neoplasms* / metabolism
  • Female
  • Humans
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Neoplasm Recurrence, Local / metabolism
  • Neoplastic Stem Cells / metabolism
  • Phenotype
  • RNA Helicases / genetics
  • RNA Helicases / metabolism
  • Trans-Activators / genetics
  • Trans-Activators / metabolism

Substances

  • MIRN508 microRNA, human
  • MicroRNAs
  • Trans-Activators
  • RNA Helicases
  • UPF1 protein, human